Search

everythinglearnresearchcommunity

for

Search:↓

New pyrazole-based inhibitors show promise for treating metabolic diseases and other conditions.

Compound 7p shows strong potential as an anticancer agent.

Animal research has greatly advanced dermatology.

Use the least toxic, most specific treatments for skin diseases, considering side effects and individual patient needs.

A compound made by Pfizer can potentially stimulate hair growth and reduce oil production, making it a good candidate for topical use.

A rigid compound with a common structural motif was successfully synthesized.

The salts have diverse molecular packing with significant hydrogen interactions.

New pyridine compounds effectively inhibit GSK3, a diabetes treatment target.

PH-762 shows promise in treating skin cancer by effectively targeting and silencing PD-1 in tumors with minimal side effects.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

Newly made nicotinamide compounds could potentially treat cancer.

The document confirms the structures of major metabolites of the CRTh2 antagonist Setipiprant and identifies minor metabolites.

A new method effectively detects toxic pyrrolizidine alkaloids in honey and flour.

Pyrene excimer nucleic acid probes are promising for detecting biomolecules accurately with potential for biological research and drug screening.

Researchers made new compounds that could potentially be developed into anticancer drugs.

PX-12 may help treat psoriasis by blocking inflammation and cell death.

The research created new azasteroids and pseudoazulenyl nitrones, which could be useful in medicine.

The new compound is a promising, less toxic alternative to finasteride for treating prostate issues.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

A new, efficient method has been developed to detect darolutamide and thalidomide, drugs used for certain hair loss and prostate cancer treatments, in pharmaceuticals and body fluids.

The document concludes that specific methods for making diazine-based drugs can lead to high yields and are important for creating effective treatments for various diseases.

The new palladium catalyst is effective and reusable for making pharmaceutical ingredients.

New pyrazole derivatives may help treat hair loss, but more testing is needed.

Topical sulfonylurea may reduce excessive hair growth caused by certain medications.

Changing the 6-position on benzopyran molecules affects insulin release, with some compounds showing strong inhibitory effects.

A peptide known for reducing wrinkles also effectively inhibits an enzyme linked to skin inflammation and acne.

New method makes important drug ingredients more easily without needing extra purification steps.

Compound 1 showed promising anticancer activity.